Epidemiology of Graves' orbitopathy
- PMID: 20467360
Epidemiology of Graves' orbitopathy
Abstract
Thyroid orbitopathy is a relatively rare disease. Prevalence data are lacking and can only be estimated. The incidence of thyroid orbitopathy has been documented in one American study (16 cases per 100,000 population per year for females and 2.9 cases per 100,000 population for males). Thyroid orbitopathy can affect every race and age group. The majority of patients present in middle age with concurrent thyrotoxicosis due to Graves' disease. The onset of orbitopathy usually coincides with the hyperthyroidism, though the two may be asynchronous by months or sometimes years. A small proportion of patients with thyroid orbitopathy have primary hypothyroidism or are euthyroid. Female patients outnumber males by 2-5 to 1. Smoking increases the risk of thyroid orbitopathy up to 8-fold.
Similar articles
-
Epidemiology of Graves' orbitopathy (GO) and relationship with thyroid disease.Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):273-9. doi: 10.1016/j.beem.2011.10.005. Best Pract Res Clin Endocrinol Metab. 2012. PMID: 22632364 Review.
-
[Epidemiology of the endocrine orbitopathy].Cesk Slov Oftalmol. 2006 Nov;62(6):373-80. Cesk Slov Oftalmol. 2006. PMID: 17319168 Slovak.
-
[Graves' orbitopathy].Orv Hetil. 2006 Jun 4;147(22):1011-7. Orv Hetil. 2006. PMID: 16913090 Review. Hungarian.
-
Optimal management of Graves orbitopathy: a multidisciplinary approach.Neth J Med. 2011 Jul-Aug;69(7):302-8. Neth J Med. 2011. PMID: 21934174 Review.
-
Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.J Clin Endocrinol Metab. 2013 Apr;98(4):1443-9. doi: 10.1210/jc.2012-3873. Epub 2013 Feb 13. J Clin Endocrinol Metab. 2013. PMID: 23408569
Cited by
-
Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.Endocr Rev. 2019 Feb 1;40(1):236-267. doi: 10.1210/er.2018-00066. Endocr Rev. 2019. PMID: 30215690 Free PMC article. Review.
-
Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease.Int J Endocrinol. 2016;2016:8129497. doi: 10.1155/2016/8129497. Epub 2016 Jun 16. Int J Endocrinol. 2016. PMID: 27413373 Free PMC article.
-
Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).Br J Ophthalmol. 2024 Jan 29;108(2):294-300. doi: 10.1136/bjo-2022-322442. Br J Ophthalmol. 2024. PMID: 36627174 Free PMC article.
-
Age differences in clinical manifestation and prognosis of thyroid eye disease.Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2301-8. doi: 10.1007/s00417-015-3156-2. Epub 2015 Sep 7. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 26344731
-
Trends in Graves' orbitopathy research in the past two decades: a bibliometric analysis.Arq Bras Oftalmol. 2022 Feb 14;85(6):590-598. doi: 10.5935/0004-2749.20220081. eCollection 2022. Arq Bras Oftalmol. 2022. PMID: 35170638 Free PMC article.